Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pugh

Showing results (131-140 of 223) with videos related to

Pageof 23
Sort By:
Head & Neck|August 23, 2019
Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology StudyRonald C Eldridge, Stephanie L Pugh, Andy Trotti, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical ProstatectomyRichard K Valicenti, Stephanie L Pugh, Edouard J Trabulsi, et al.
American Journal of Hematology|August 5, 2021
Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell diseaseJennifer N Longoria, Norma L Pugh, Victor Gordeuk, et al.
Journal of the National Cancer Institute|May 22, 2016
Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617Bree R Eaton, Stephanie L Pugh, Jeffrey D Bradley, et al.
Journal of Neuroinflammation|February 28, 2007
Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenesPerdita L Pugh, Martin P Vidgeon-Hart, Tracey Ashmeade, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 5, 2014
The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trialKaren E Hoffman, Stephanie L Pugh, Jennifer L James, et al.
Frontiers in Integrative Neuroscience|March 16, 2023
Interdisciplinary views of fNIRS: Current advancements, equity challenges, and an agenda for future needs of a diverse fNIRS research communityEmily J Doherty, Cara A Spencer, Jeremy Burnison, et al.
Implementation Science Communications|July 31, 2023
Implementing practice facilitation in research: how facilitators spend their time guiding practices to improve blood pressure controlKent F Sutton, Erica L Richman, Jennifer R Rees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Reply to F. Felix et al and M.F. Fay et alCaroline Happold, Thierry Gorlia, Oliver Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.
Pageof 23

Showing results (131-140 of 223) with videos related to

Sort By:
Pageof 23
Head & Neck|August 23, 2019
Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology StudyRonald C Eldridge, Stephanie L Pugh, Andy Trotti, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical ProstatectomyRichard K Valicenti, Stephanie L Pugh, Edouard J Trabulsi, et al.
American Journal of Hematology|August 5, 2021
Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell diseaseJennifer N Longoria, Norma L Pugh, Victor Gordeuk, et al.
Journal of the National Cancer Institute|May 22, 2016
Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617Bree R Eaton, Stephanie L Pugh, Jeffrey D Bradley, et al.
Journal of Neuroinflammation|February 28, 2007
Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenesPerdita L Pugh, Martin P Vidgeon-Hart, Tracey Ashmeade, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 5, 2014
The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trialKaren E Hoffman, Stephanie L Pugh, Jennifer L James, et al.
Frontiers in Integrative Neuroscience|March 16, 2023
Interdisciplinary views of fNIRS: Current advancements, equity challenges, and an agenda for future needs of a diverse fNIRS research communityEmily J Doherty, Cara A Spencer, Jeremy Burnison, et al.
Implementation Science Communications|July 31, 2023
Implementing practice facilitation in research: how facilitators spend their time guiding practices to improve blood pressure controlKent F Sutton, Erica L Richman, Jennifer R Rees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Reply to F. Felix et al and M.F. Fay et alCaroline Happold, Thierry Gorlia, Oliver Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.
Pageof 23